Interaction of NAP-22 with brain glutamic acid decarboxylase (GAD)

被引:12
|
作者
Maekawa, Shohei [1 ]
Kobayashi, Yuumi [1 ]
Odagaki, Sin-Ichi [1 ]
Makino, Midori [1 ]
Kumanogoh, Haruko [2 ]
Nakamura, Shun [3 ]
Morita, Mitsuhiro [1 ]
Hayashi, Fumio [1 ]
机构
[1] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 6578501, Japan
[2] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Div Biochem & Cellular Biol, Kodaira, Tokyo 1870031, Japan
[3] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan
关键词
Lipid raft; GAD65/67; NAP-22; Synapse; CALMODULIN-BINDING PROTEIN; GAMMA-AMINOBUTYRIC-ACID; CLEFT-PALATE; MICE LACKING; ISOFORM; BASP1; PHOSPHORYLATION; LOCALIZATION; PURIFICATION; MARCKS;
D O I
10.1016/j.neulet.2013.01.030
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
NAP-22 (also called BASP1 or CAP-23) is a neuron-enriched protein localized mainly in the synaptic vesicles and the synaptic plasma membrane. Biochemically, it is recovered in the lipid raft fraction. In order to understand the physiological function of the neuronal lipid raft, NAP-22 binding proteins were screened with a pull-down assay. Glutamic acid decarboxylase (GAD) was detected through LC-MS/MS, and Western blotting using a specific antibody confirmed the result. Two isoforms of GAD, GAD65 and GAD67, were expressed in bacteria as GST-fusion forms and the interaction with NAP-22 was confirmed in vitro. Partial co-localization of NAP-22 with GAD65 and GAD67 was also observed in cultured neurons. The binding showed no effect on the enzymatic activity of GAD65 and GAD67. These results hence suggest that NAP-22 could participate in the transport of GAD65 and GAD67 to the presynaptic termini and their retention on the synaptic vesicles as an anchoring protein. (c) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:50 / 54
页数:5
相关论文
共 50 条
  • [41] Autoimmunity to glutamic acid decarboxylase (GAD) in insulin-dependent diabetes mellitus
    Kaufman, DL
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S54 - S54
  • [42] Quaternary structure of the neuronal protein NAP-22 in aqueous solution
    Epand, RM
    Braswell, EH
    Yip, CM
    Epand, RF
    Maekawa, S
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2003, 1650 (1-2): : 50 - 58
  • [43] GLUTAMIC-ACID DECARBOXYLASE (GAD) ACTIVITY IN CSF OF PATIENTS WITH CNS DISEASE
    TADA, H
    MATSUI, T
    HORI, M
    SATO, Y
    WATANABE, K
    KANEKO, K
    OTSUKA, C
    BRAIN & DEVELOPMENT, 1983, 5 (02): : 234 - 234
  • [44] Glutamic acid decarboxylase (GAD) antibodies in epilepsy: Diagnostic yield and therapeutic implications
    Lilleker, James B.
    Biswas, Viveka
    Mohanraj, Rajiv
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2014, 23 (08): : 598 - 602
  • [45] Renal glutamic acid decarboxylase (GAD): Solubility and effects of ATP, phosphate and chloride
    Bandzuchova, E
    Tursky, T
    Lassanova, M
    BIOLOGIA, 1997, 52 (06) : 707 - 715
  • [46] Engineered variants of human glutamic acid decarboxylase (GAD) and autoantibody epitope recognition
    Primo, ME
    Anton, EA
    Villanueva, AL
    Poskus, E
    Ermácora, MR
    CLINICAL IMMUNOLOGY, 2003, 108 (01) : 38 - 45
  • [47] IMMUNOCYTOCHEMICAL LOCALIZATION OF GLUTAMIC-ACID DECARBOXYLASE (GAD) IN RAT CORPUS STRIATUM
    RIBAK, CE
    ANATOMICAL RECORD, 1978, 190 (02): : 521 - 521
  • [48] NEW MICROASSAY METHOD FOR L-GLUTAMIC ACID DECARBOXYLASE (GAD) ACTIVITY
    KIMURA, H
    KURIYAMA, K
    JAPANESE JOURNAL OF PHARMACOLOGY, 1975, 25 (02): : 189 - 195
  • [49] EXPRESSION OF GLUTAMIC-ACID DECARBOXYLASE (GAD) IN THE AUTONOMIC NERVOUS-SYSTEM
    ZANONE, MM
    PEAKMAN, M
    PETERSEN, JS
    VERGANI, D
    DIABETOLOGIA, 1994, 37 : A73 - A73
  • [50] Reactivity of islet cell antibodies (ICA) to recombinant glutamic acid decarboxylase (GAD)
    Guazzarotti, L
    Thivolet, C
    Tardivel, I
    Chevalier, A
    Carel, JC
    JOURNAL OF AUTOIMMUNITY, 1995, 8 (06) : 901 - 914